Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement

BACKGROUND: The European Respiratory Society recently published an important statement reviewing available evidence on diagnosis and treatment of lung disease associated to alpha-1 antitrypsin deficiency (AATD). Several issues on this topic still remain unresolved and subject of interpretation accor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramegna, Andrea, Aliberti, Stefano, Confalonieri, Marco, Corsico, Angelo, Richeldi, Luca, Vancheri, Carlo, Blasi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174569/
https://www.ncbi.nlm.nih.gov/pubmed/30338069
http://dx.doi.org/10.1186/s40248-018-0153-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174569/
https://www.ncbi.nlm.nih.gov/pubmed/30338069
http://dx.doi.org/10.1186/s40248-018-0153-4

Ejemplares similares